Overview

The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography

Status:
Completed
Trial end date:
2018-09-04
Target enrollment:
Participant gender:
Summary
an interventional study to measure the possible effects of spironolactone ( an aldosterone antagonist) on the incidence of acute kidney injury after coronary angiography
Phase:
Phase 2
Details
Lead Sponsor:
Alhasan Mujtaba Abdul-Wahid
Collaborator:
Ministry of Health-Basra Health Directorate-Al-Sader Teaching Hospital
Treatments:
Spironolactone